Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) Gross Margin (2017 - 2026)

Nutex Health (NUTX) has disclosed Gross Margin for 17 consecutive years, with 42.37% as the latest value for Q1 2026.

  • For Q1 2026, Gross Margin fell 1350.0% year-over-year to 42.37%; the TTM value through Mar 2026 reached 47.47%, down 130.0%, while the annual FY2025 figure was 50.76%, 987.0% up from the prior year.
  • Gross Margin hit 42.37% in Q1 2026 for Nutex Health, up from 30.42% in the prior quarter.
  • Across five years, Gross Margin topped out at 57.83% in Q3 2025 and bottomed at 93.21% in Q3 2022.
  • Average Gross Margin over 5 years is 22.64%, with a median of 27.82% recorded in 2024.
  • Year-over-year, Gross Margin tumbled -15764bps in 2022 and then soared 10448bps in 2023.
  • Nutex Health's Gross Margin stood at 0.99% in 2022, then soared by 1821bps to 18.97% in 2023, then soared by 190bps to 54.98% in 2024, then tumbled by -45bps to 30.42% in 2025, then skyrocketed by 39bps to 42.37% in 2026.
  • According to Business Quant data, Gross Margin over the past three periods came in at 42.37%, 30.42%, and 57.83% for Q1 2026, Q4 2025, and Q3 2025 respectively.